Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Las Vegas Sands Corp. (LVS) vs Stryker Corporation (SYK) Price & Performance

Las Vegas Sands Corp.Trade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Las Vegas Sands Corp. vs Stryker Corporation — how do they compare? Las Vegas Sands Corp. trades at $45.69 (market cap $30.36B), while Stryker Corporation trades at $315.92 (market cap $122.35B). The key difference: Stryker Corporation is far larger — about 4× Las Vegas Sands Corp.'s market cap, and Las Vegas Sands Corp. pays the higher dividend (2.4%). Which is the better fit depends on your goals.

LVSSYK
Market Cap
$30.36B$122.35B
Sector
Consumer CyclicalTechnology
52-Week High
$69.49$403.53
52-Week Low
$44.78$282.58
Enterprise Value
$42.75B$134.10B
Dividend Yield
2.4%1%

Returns comparison

Trailing returns across standard periods

About Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.

Read more on LVS

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK